Rating #44
Chris Davis
Davis Selected Advisers
Portfolio value
Stocks
Performance
1 Year
+20.65%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Chris Davis’ Portfolio: Q4 2025
Top10 stocks: 50.29% of the portfolio
Chris Davis’ Trades: Q4 2025
Adds
New Buys
Sold Outs
Cuts
1.39ppt
0.56ppt
0.38ppt
0.05ppt
0.06ppt
0.27ppt
0.87ppt
0.06ppt
0.79ppt
0.00ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  CTRA | Add +63.64% | $25.20 | $318.88M | 1.39ppt | |
2  TSN | Add +28.76% | $54.92 | $157.37M | 0.56ppt | |
3  USB | Add +13.43% | $49.19 | $128.40M | 0.38ppt | |
4  PINS | Add +49.54% | $28.79 | $112.57M | 0.05ppt | |
5  CVS | Add +11.90% | $78.84 | $106.98M | 0.06ppt | |
Add +38.57% | $497.53 | $102.45M | 0.27ppt | ||
Add +12.57% | $285.73 | $99.48M | 0.87ppt | ||
8  MGM | Add +11.97% | $33.93 | $97.27M | 0.06ppt | |
9  VTRS | Add +12.74% | $10.79 | $95.30M | 0.79ppt | |
10  TXN | Add +23.12% | $171.26 | $91.76M | 0.00ppt |
Chris Davis’ Holdings: Q4 2025
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  COF | National Banks | $82.71 | Add +2.80% | 8.61M | $2.09B | 9.38% 0.08ppt | 1.59% | 46 Quarters | Q4 2025 | |
2 USB | National Banks | $44.51 | Add +13.43% | 22.04M | $1.18B | 5.29% 0.38ppt | 1.42% | 64 Quarters | Q4 2025 | |
3  META | Computer Programming & Data | $150.74 | Add +2.18% | 1.75M | $1.16B | 5.20% -1.38ppt | 0.07% | 41 Quarters | Q4 2025 | |
4  AMAT | Semiconductors | $74.75 | Cut -24.36% | 4.20M | $1.08B | 4.85% -1.08ppt | 0.52% | 57 Quarters | Q4 2025 | |
5 CVS | Retail-Drug Stores | $49.39 | Add +11.90% | 12.76M | $1.01B | 4.55% 0.06ppt | 1.01% | 29 Quarters | Q4 2025 | |
6 MGM | Hotels & Motels | $37.56 | Add +11.97% | 26.82M | $978.67M | 4.40% 0.06ppt | 9.84% | 10 Quarters | Q4 2025 | |
Computer Programming & Data | $71.03 | Add +12.57% | 3.12M | $976.17M | 4.39% 0.87ppt | 0.03% | 41 Quarters | Q4 2025 | ||
8 VTRS | Pharmaceutical Pres | $13.01 | Add +12.74% | 78.18M | $973.32M | 4.37% 0.79ppt | 6.71% | 21 Quarters | Q4 2025 | |
9  MKL | Casualty Insurance | $1129.73 | Add +11.15% | 415.16K | $892.50M | 4.01% 0.28ppt | 3.27% | 87 Quarters | Q4 2025 | |
10 CTRA | Crude Oil & Gas | $25.18 | Add +63.64% | 32.54M | $856.39M | 3.85% 1.39ppt | 4.26% | 3 Quarters | Q4 2025 | |
11  AMZN | Retail-Catalog & Mail-Order | $60.34 | Add +9.28% | 3.43M | $791.55M | 3.56% -0.04ppt | 0.03% | 84 Quarters | Q4 2025 | |
12  WFC | National Banks | $31.67 | Add +6.06% | 8.26M | $769.65M | 3.46% 0.05ppt | 0.26% | 87 Quarters | Q4 2025 | |
13 TSN | Poultry Processing | $57.73 | Add +28.76% | 12.83M | $751.95M | 3.38% 0.56ppt | 3.72% | 7 Quarters | Q4 2025 | |
14  BRK.A | Casualty Insurance | $122960.04 | Cut -5.51% | 943.00 | $711.78M | 3.20% -0.73ppt | 0.07% | 82 Quarters | Q4 2025 | |
15  TECK | Diversified Metals and Mining | $30.39 | Add +9.03% | 12.02M | $575.62M | 2.59% 0.06ppt | 2.46% | 18 Quarters | Q4 2025 | |
16 TXN | Semiconductors | $62.06 | Add +23.12% | 2.85M | $495.01M | 2.22% 0.00ppt | 0.31% | 78 Quarters | Q4 2025 | |
17  SOLV | Surgical Instruments | $55.96 | Add +12.73% | 6.22M | $492.88M | 2.22% 0.11ppt | 3.57% | 7 Quarters | Q4 2025 | |
18  UNH | Medical Service Plans | $309.78 | Add +11.77% | 1.27M | $420.37M | 1.89% -0.16ppt | 0.14% | 52 Quarters | Q4 2025 | |
19  BRK.B | Casualty Insurance | $225.00 | Add +38.57% | 739.88K | $371.91M | 1.67% 0.27ppt | 0.03% | 64 Quarters | Q4 2025 | |
20  CB | Casualty Insurance | $144.35 | Add +10.86% | 1.19M | $370.38M | 1.66% 0.09ppt | 0.30% | 40 Quarters | Q4 2025 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.